3Schmidt—wolf I G H.Negrin R S.Kiem H P.et al.Use of a SCID mouse／Human lymphoma model to evaluate cytokineinduced killer cells with potent antitumor cell activity[J].J Exp Med,1991,174:139～149.
4Lu P H,Negrin R S. A novel population of expanded human CD3^+CD56^+ cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency[J]. J Immunol, 1994,153 : 1687-1696.
5Schmidt-wolf I G H,Lefterova P,Mehta B A, et al. Phenetypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-inducted keller cells [J]. Exp Hematol, 1993,21 (13) ; 1673 -- 1679.
6Hoyle C,Bangs C D,Chang P,et al. Expansion of philadelphia chromosomenegative CD3^+CD56^+ cytotoxic cells from chronic myeloid luekemia patients:in vitro and in vivo efficacy in severe combined immunodeficiency disease mice[J]. Blood, 1998,92 (9): 3318-- 3327.
7Zoll B,Lefterova P,Csipai M,et al. Generation of cytokine-lnduced killer cells using exogenous interleukin-2,-7,-12[J]. Cancer Immunol lmmunother,1998,47(4 ) : 221 -- 226.
8Mehata B A. Schmidt-wolf I G H,Weissman I L,et al. Two pathways of exocytosis of cytoplasmic granule contents and target cell killing by cytokineinduced CD3^+CD56^+ killer cells [J].Blood, 1995,86 (9):3493-- 3499.
9Verneris M R, Kornacker M, Mainlander V, et al. Resistance of ex vivo expanded CD3^+CD56^+ T cells to Fas-mediated apoptosis [J]. Cancer Immunol Immunother, 2000,49 (6) : 335 - 345.
10Linn Y C,Lau L C,Hui K M. Generation of cytokine-induced cells from leukaemic samples with in vitro cytotoxicity against autologous and allogeneic leukaemic blasts [J ]. British Journal of Haematology, 2002,116 : 78-- 86.
